Immunomodulatory treatment of myelodysplastic syndromes: antithymocyte globulin, cyclosporine, and alemtuzumab
about
Immune Mechanisms in Myelodysplastic SyndromeThe relationship between idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and autoimmunity.Current therapy of myelodysplastic syndromesImmunological derangement in hypocellular myelodysplastic syndromes.Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasmPD-1 signaling and inhibition in AML and MDS.
P2860
Immunomodulatory treatment of myelodysplastic syndromes: antithymocyte globulin, cyclosporine, and alemtuzumab
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Immunomodulatory treatment of ...... cyclosporine, and alemtuzumab
@ast
Immunomodulatory treatment of ...... cyclosporine, and alemtuzumab
@en
Immunomodulatory treatment of ...... cyclosporine, and alemtuzumab
@nl
type
label
Immunomodulatory treatment of ...... cyclosporine, and alemtuzumab
@ast
Immunomodulatory treatment of ...... cyclosporine, and alemtuzumab
@en
Immunomodulatory treatment of ...... cyclosporine, and alemtuzumab
@nl
prefLabel
Immunomodulatory treatment of ...... cyclosporine, and alemtuzumab
@ast
Immunomodulatory treatment of ...... cyclosporine, and alemtuzumab
@en
Immunomodulatory treatment of ...... cyclosporine, and alemtuzumab
@nl
P2093
P2860
P3181
P1476
Immunomodulatory treatment of ...... cyclosporine, and alemtuzumab
@en
P2093
A. John Barrett
Ankur R. Parikh
Matthew J. Olnes
P2860
P304
P3181
P356
10.1053/J.SEMINHEMATOL.2012.07.004
P407
P577
2012-10-01T00:00:00Z